John Childs

United States; Waltham Massachusetts United States; Massachusetts United States; North America
Is it you?
Investor info
Type
Angel Investors
Stage focus
  • Seed Round
Industry focus
Description
John Childs is a Co-Founder and serves as Chairman, Chief Executive Officer and Partner at J.W. Childs Associates. He was a Board Member at New Haven Pharmaceuticals. He serves as Board Member at Simcom Training Centers. He is an Angel Investor. Childs has been Chairman and Chief Executive Officer of J.W. Childs, a private equity firm and one of the Company's principal stockholders, since 1995. From 1991 to 1995, Childs was Senior Managing Director of Thomas H. Lee Partners, a private equity firm, and from 1987 to 1990 was a Managing Director of Thomas H. Lee Partners. Prior to 1987, Childs was associated with the Prudential Insurance Company of America ("Prudential"), an insurance company, for 17 years where he held various executive positions in the investment area, ultimately serving as Senior Managing Director in charge of the Capital Markets Group at which time he was responsible for Prudential's approximately $77 billion fixed income portfolio, including all the Capital Markets Group's investments in leveraged acquisitions. He is currently a Chairman of Kosta Browne Winery, LLC and Director of KeyImpact Sales & Systems, Inc., Esselte Ltd., a supplier of office supplies, WS Packaging Group, Inc., a company that manufactures pressure sensitive labels for the food, beverage, personal care, household, commercial, promotional, industrial, direct mail, and pharmaceutical markets, and Simcom, Inc., a provider of aircraft simulator training services. He was previously a director at Sunny Delight Beverages Co., a producer of juice-based drinks in North America, Advantage Sales and Marketing, Inc., a sales and marketing agency, and CHG Healthcare Services, Inc., a healthcare staffing provider. Childs's experience serving as a director of various companies, including his experience with Mattress Firm, and his expertise in private equity led to the conclusion that he should serve as a director of the Company. He serves as the Board Member of Biohaven Pharmaceutical.
Relevant investments
  • Company
    Amount
    Round
  • Example example company Inc
    $ 1,000,000
    Investor meetings
  • Company & Company
    € 11,000,000
    Series C funding
  • Example
    $ 524,000
    Seed round A
Show more
Connected people
Email visible after logging in
  • Example Example
    Example Exampleexample[email protected]
  • Example Exampleexample
    Example Exampleexample
  • Notexample Examplenot
    Notexample Examplenotexample example[email protected]
  • Example Examplenotexample
    Example Examplenotexampleexample example[email protected]
  • Example Example
    Example Exampleexample[email protected]
  • Example Example
    Example Exampleexample[email protected]
Show more
See other investors focused on
Manufacturing
Made with in San Francisco, Valencia, Oslo, Cherkasy and Warsaw© 2015-     Foundersuite, Inc.